AACR Journals Webinar
on CAR T Cell Manufacturing
Moderated by: Tanya Bondar, PhD
Deputy Editor, Blood Cancer Discovery
Watch the recording of the AACR Journals Webinar on CAR T Cell Manufacturing featuring a panel of experts representing major stakeholders in the field as they discuss future goals and current barriers in CAR T cell manufacturing, and brainstorm how these barriers can be overcome. CAR T cell production process is a major determinant of efficacy, reproducibility, and accessibility of CAR T cell therapies. The Blood Cancer Discovery review article, "Scalable Manufacturing of CAR T Cells for Cancer Immunotherapy", provides the necessary background.
Stay tuned for the Q&A session at the end of the recording.
About the Featured Panelists:
Mohamed Abou-El-Enein, MD, PhD is Associate Professor of Medicine, Pediatrics, and Stem Cell Biology & Regenerative Medicine, University of South California (USC), Director of the good manufacturing practices (GMP) facility, Children's Hospital Los Angeles (CHLA) and Executive Director, Joint USC/CHLA Cell Therapy Program.
Nirali N. Shah, MD, MHSc is NIH Lasker Clinical Research Scholar, and NIH Distinguished Scholar and Head, Hematologic Malignancies Section, Pediatric Oncology Branch, National Cancer Institute.
Peter Marks, MD, PhD is Director Center for Biologics Evaluation and Research, U.S. Food and Drug Administration.
Bruce L. Levine, PhD is Barbara and Edward Netter Professor in Cancer Gene Therapy, Deputy Director-Technology Innovation and Assessment, Center for Cellular Immunotherapies, University of Pennsylvania, and Founding Director, Clinical Cell and Vaccine Production Facility, University of Pennsylvania.
Nina Bauer, PhD is Head of Commercial, Gene Editing and Novel Modalities, MilliporeSigma.
Anthony R. Welch, PhD is Program Director/Project Officer, Biological Resources Branch, Development Therapeutics Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute.